News
Aurum Equity Partners announce USD 400 million investment to build next-gen data centre in Hyderabad ...
Akston Biosciences Corporation and Biolexis, a Strides Group Company, today announced results from a Phase II/III clinical trial in India of the SARS-CoV-2 vaccine, AKS-452, in which 1,600 healthy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback